What is CSTL's P/E ratio?

CASTLE BIOSCIENCES INC (CSTL) currently trades at a P/E ratio of 140.89.

CASTLE BIOSCIENCES INC reports a Return on Equity (ROE) of -2.78%.

What is CSTL's dividend yield?

CASTLE BIOSCIENCES INC offers a dividend yield of 0.00%.

What is CSTL's Deepscope Quality Score?

Deepscope rates CSTL's overall financial quality at 15 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy CSTL?

Deepscope's AI Timing Score for CSTL is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does CSTL belong to?

CASTLE BIOSCIENCES INC is classified under the Healthcare >> Diagnostics & Research sector on the NASDAQ exchange.

Cổ phiếu CSTL (NASDAQ) | CASTLE BIOSCIENCES INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-12 | FS: 2026-03-31)

CSTL

CASTLE BIOSCIENCES INC

US:NASDAQ STOCK Healthcare >> Diagnostics & Research News 99

USD 20.70

-0.31 (-1.48%) Day Change

Watchlist Portfolio Compare Chart

140.89

P/E

0.02

D/E

-2.8%

ROE

-2.3%

ROA

0.00%

Div Yield

-1.11

PEG

CASTLE BIOSCIENCES INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 20.70 Price -0.31 (-1.48%) Day Change	NEWS SCORE: 99

CSTL Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 15) và Thời điểm mua ...(Sign In to See)...

Loading chart...

15 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ P/E tương đối cao
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng

41%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	20.70
PBV / Sector	1.38 / -23.09 GOOD
Earning Per Share	-0.42

PE / Sector	140.89 / 37.68
PEG or PE/Growth / Sector	-1.11 / 1.40
Average 1M Daily Value	6.86 M
Average 1W Daily Value	4.55 M GREAT

Yếu tố Kỹ thuật

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-3.78 / 12.69
NPM Average (%) / Sector	-16.09 / 7.99
NPM Change Average (%) / Sector	-110.40 / -5.21
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-2.34 / 11.23
ROA Average (%) / Sector	-6.15 / -82.28
ROA Change Average (%) / Sector	-102.03 / 159.98
ROE (%) / Sector	-2.78 / -86.57
ROE Average (%) / Sector	-7.08 / -2.21
ROE Change Average (%) / Sector	-103.48 / -44.18
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.25
Dividend Average (%) / Sector	N/A / 1.20
Dividend Change Average (%) / Sector	N/A / 7.38

Chi tiết đăng ký

Analyze Date	2026-06-13 11:13:41
Symbol	CSTL
Name	CASTLE BIOSCIENCES INC
Sector	Healthcare >> Diagnostics & Research
Market	NASDAQ
Listed Shares	30.33 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	637.23 / 31,572.33

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1500 W. Parkwood Ave, Friendswood, TX, United States, 77546

Phone: 866 788 9007

Website: https://castlebiosciences.com

Employees: 942

Sector: Healthcare >> Diagnostics & Research

Description: Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), atopic dermatitis (AD), and uveal melanoma. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts the likelihood of a positive sentinel lymph node and the risk of metastasis for patients with invasive cutaneous melanoma; TissueCypher, a risk stratification spatialomics test to predict future development of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, and low-grade dysplasia BE; AdvanceAD-Tx, a non-invasive GEP test which is designed to guide systemic treatment selection for patients aged 12 years and older with moderateto-severe AD; DecisionDx-SCC, a GEP test for cutaneous squamous cell carcinoma; and MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions. It also provides DecisionDx-UM, a risk stratification GEP test that predicts the risk of metastasis for patients with uveal melanoma. The company offers its products to dermatology and gastroenterology markets. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.